Study guide
6.2 Electronic Prescribing & Electronic Prescriptions for Controlled Substances (EPCS)
Alabama MPJE Pharmacy Jurisprudence Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Board of Pharmacy Governance & Pharmacist Licensure
1.1 Alabama State Board of Pharmacy: Structure, Powers, Rulemaking & the 2026 Nine-Member Board 1.2 Pharmacist Licensure Requirements: Examination, Education, Background Check & Reciprocity 1.3 Pharmacy Interns, Externs & Preceptor Requirements: 1,500 Practical Hours & Supervision Standards
2 Chapter 2: Pharmacy Support Personnel, Ratios & Professional Standards
2.1 Pharmacy Technicians: Registration, Qualifications, Scope of Duties & Tiered Ratios 2.2 License Renewal Cycles, Continuing Education (CE) & Inactive Status 2.3 Disciplinary Grounds, Sanctions, Administrative Hearings & Impaired Pharmacist Rehabilitation
3 Chapter 3: Prescribing Authority, Practitioner Scopes & Corresponding Responsibility
3.1 Prescriptive Authority by Profession: Independent vs. Limited Scopes 3.2 Mid-Level Prescribing: PAs, CRNPs, CNMs, QACSC & Limited Purpose Schedule II Permits (LPSP) 3.3 Corresponding Responsibility, Legitimate Medical Purpose & Red Flags for Controlled Substance Diversion
4 Chapter 4: Opioids, Controlled Substance Clinical Safeguards & Naloxone Access
4.1 Opioid Prescribing Standards: ALBME Risk & Abuse Mitigation, MME Thresholds & Pain-Management Registration 4.2 Overdose Prevention: Statewide Naloxone Standing Order, Co-Prescribing & Pharmacist Dispensing Protocols 4.3 Alabama Prescription Drug Monitoring Program (PDMP): Dispenser Daily Reporting & Prescriber Query Mandates
5 Chapter 5: Clinical Services, Immunizations & Collaborative Practice
5.1 Pharmacist Immunization Authority, Protocols & Training Standards 5.2 Collaborative Drug Therapy Management (CDTM) & Collaborative Practice Agreements 5.3 Patient Counseling & Prospective Drug Utilization Review (DUR) Standards
6 Chapter 6: Prescription Validity, Electronic Prescribing & Security Standards
6.1 Prescription Form Validity: Written, Oral/Telephone & Facsimile Requirements 6.2 Electronic Prescribing & Electronic Prescriptions for Controlled Substances (EPCS) 6.3 Alabama Generic Drug Substitution: Two-Signature Line Law & Therapeutic Equivalence
7 Chapter 7: Prescription Processing, Labeling, Packaging & Emergency Dispensing
7.1 Prescription Labeling Standards & Expiration / Beyond-Use Dating 7.2 Federal Packaging Mandates: Poison Prevention Packaging Act (PPPA) & Child-Resistant Containers 7.3 Emergency Prescription Dispensing: 72-Hour Supply Rule & Disaster Provisions 7.4 Partial Filling of Prescriptions: Non-Controlled, Schedule II & Schedules III–V
8 Chapter 8: Prescription Transfers, Delivery & Remote Pharmacy Services
8.1 Prescription Transfer Rules: Non-Controlled vs. Controlled Substances 8.2 Prescription Delivery, Mail-Order Distribution & Out-of-State Permits 8.3 Patient Records, Confidentiality & Permitted Health Information Disclosures 8.4 Remote Pharmacist Work, Off-Site Order Entry & Off-Site Vaccine Order Processing
9 Chapter 9: Pharmacy Facility Standards, Security & Operational Supervision
9.1 Pharmacy Facility Permits: Application, Inspection, Renewal & Change of Ownership 9.2 Prescription Department Technical Equipment, References & Storage Standards 9.3 Pharmacy Security, Keys & Controlled Access Standards 9.4 Supervising Pharmacist Responsibilities & Temporary Absence
10 Chapter 10: Controlled Substances: Scheduling, Ordering, Inventory & Recordkeeping
10.1 Controlled Substance Scheduling: Federal Framework & Alabama State Variations 10.2 Controlled Substance Ordering & Procurement: DEA Form 222, CSOS & Invoicing 10.3 Controlled Substance Inventory Standards: Alabama Annual Inventory on January 15 10.4 Controlled Substance Records, 2-Year Retention & Filing Systems 10.5 Drug Distribution & Supply-Chain Security: DSCSA, Wholesale Distribution & Alabama Permits
11 Chapter 11: Controlled Substance Diversion Control, Disposal & Precursor Regulation
11.1 Theft and Loss of Controlled Substances: DEA Form 106 & Alabama Board Reporting Requirements 11.2 Controlled Substance Disposal, Destruction & Reverse Distribution 11.3 Ephedrine and Pseudoephedrine Sales Restrictions: Federal & Alabama Law 11.4 Non-Prescription Products: OTC Labeling, Repackaging, Exempt Narcotics & Restricted Distribution
12 Chapter 12: Compounding Standards, Institutional Practice & Medication Safety
12.1 Non-Sterile Compounding Standards: USP <795>, Beyond-Use Dating & Alabama Standards 12.2 Sterile Compounding & Hazardous Drug Handling: USP <797>, USP <800> & Facility Requirements 12.3 Institutional Pharmacy Practice: Absence of Pharmacist, Night Cabinets, Stat Cabinets & Emergency Kits 12.4 Medication Safety, Drug Recalls (Classes I-III), Adulteration, Misbranding & Return/Reuse Prohibitions
6.2 Electronic Prescribing & Electronic Prescriptions for Controlled Substances (EPCS)
Key Takeaways Explain This Topic AI
Electronic Prescriptions for Controlled Substances (EPCS) are governed by federal DEA regulations under 21 C.F.R. Part 1311, requiring third-party software certification, identity proofing, two-factor authentication, and digital signatures.
Prescribers must authenticate EPCS orders using two out of three distinct authentication factors: something you know (password/PIN), something you have (hardware token/cryptokey), or something you are (biometric data).
Alabama electronic prescription transmission rules require direct, tamper-proof electronic routing from prescriber software to pharmacy management systems without intermediary interception, data manipulation, or commercial marketing steering.
EPCS transmissions cannot be downgraded or converted into computer-generated faxes or printed paper orders to circumvent DEA electronic controls; transmission failures require distinct fallback notations and inter-pharmacy verification.
All electronic prescription records, cryptographic audit trails, and dispensing histories must be retained in an electronic format for a minimum of two (2) years and verified daily by dispensing pharmacists via signed audit printouts or logs.
Last updated: September 2026
6.2 Electronic Prescribing & Electronic Prescriptions for Controlled Substances (EPCS)
Note
Technological Integration & Regulatory Authority : Electronic prescribing represents the standard of modern pharmacy practice, designed to eliminate illegible handwriting, mitigate diversion, and streamline dispensing workflows. However, the transmission of electronic orders—especially for controlled substances—is subject to rigorous federal standards codified in Title 21 of the Code of Federal Regulations, Part 1311 (21 C.F.R. Part 1311: Requirements for Electronic Orders and Prescriptions). In Alabama, electronic prescribing must simultaneously satisfy Board of Pharmacy regulations under Ala. Admin. Code r. 680-X-2 and the Alabama Uniform Controlled Substances Act.
Electronic Prescriptions for Controlled Substances (EPCS) introduce sophisticated cryptographic security protocols to ensure that an electronic transmission cannot be intercepted, altered, forged, or repudiated. While electronic prescribing of non-controlled legend medications allows simpler electronic data exchanges, EPCS demands strict compliance with federal identity proofing, two-factor authentication, software certification, and digital signature binding.
DEA EPCS Technical Architecture & Third-Party Auditing
Under 21 C.F.R. Part 1311, an electronic prescription for a controlled substance in Schedule II, III, IV, or V is legally valid only if both the prescribing electronic health record (EHR) application and the pharmacy dispensing application comply fully with DEA EPCS technical rules .
Independent Third-Party Certification
Neither a prescriber nor a pharmacy may utilize an electronic prescribing software suite for controlled substances until the application has obtained formal, written certification from an approved independent third-party auditor or certifying organization (e.g., Drummond Group, CCHIT) verifying that the software satisfies all requirements of 21 C.F.R. Part 1311. The audit report must confirm that the application correctly enforces identity proofing, two-factor authentication, logical access controls, digital signing, tamper-evident record storage, and comprehensive audit trails.
Prescriber Identity Proofing (NIST SP 800-63 Standards)
Before a practitioner is granted access to electronically sign controlled substance prescriptions, their identity must be verified through rigorous identity proofing meeting National Institute of Standards and Technology (NIST) Special Publication 800-63-3 criteria (Assurance Level 3):
Institutional Credentialing : For practitioners affiliated with an institutional hospital or health system, an authorized institutional credentialing committee may conduct in-person identity proofing, verifying the practitioner's state medical license, DEA registration, and government-issued photographic identification.
Individual Credentialing : For independent or non-institutional practitioners, identity proofing is conducted by an approved Third-Party Credential Service Provider (CSP) or Certification Authority (CA), utilizing in-person or high-assurance remote identity verification mechanisms (e.g., credit bureau knowledge-based authentication combined with biometric financial verification). +---------------------------------------------------------------------------------------------------------+
- | EPCS Prescriber Onboarding & Signing Workflow |
- +---------------------------------------------------------------------------------------------------------+
- | 1. Identity Proofing: NIST 800-63-3 Level 3 verification by CSP or Institutional Credentialing Board |
- | 2. Logical Access Controls: Two designated clinic individuals approve EPCS signing permissions |
- | 3. Credential Issuance: Prescriber issued two-factor authentication (2FA) credential |
- | 4. Digital Signing: Prescriber applies 2FA to cryptographically sign EPCS transmission |
- | 5. Pharmacy Decryption: Pharmacy software validates cryptographic hash and audit trail |
- +---------------------------------------------------------------------------------------------------------+
- Separation of Duties: Logical Access Controls
Once identity proofing is completed, an EHR software system must enforce a two-individual access control protocol before enabling EPCS permissions for a prescriber. One individual must be an authorized practice administrator who verifies the practitioner's identity and credentials, and the second individual must be the practitioner who enters their newly issued authentication credential. This separation of duties prevents a rogue employee or software administrator from unilaterally activating EPCS signing privileges.
Two-Factor Authentication (2FA) & Digital Signatures
To digitally sign an EPCS order, DEA regulations strictly mandate that the prescriber utilize two-factor authentication (2FA) . The prescriber must use credentials drawn from two of three distinct authentication categories : +---------------------------------------------------------------------------------------------------------+
- | DEA Two-Factor Authentication Categories |
- +---------------------------------------------------------------------------------------------------------+
- | Authentication Category | Technical Description | Permissible Practical Examples |
- +-------------------------------+-----------------------------------------+--------------------------------+
- | 1. Knowledge Factor | Something you know | Master Password, Secret PIN |
- +-------------------------------+-----------------------------------------+--------------------------------+
- | 2. Possession Factor | Something you have | Hardware Cryptographic Token, |
- | | (Must be separate from device) | Smart Card, Key Fob Generator |
- +-------------------------------+-----------------------------------------+--------------------------------+
- | 3. Inherence Factor | Something you are (Biometric) | Fingerprint Scan, Iris Scan, |
- | | | Facial Geometry Recognition |
- +-------------------------------+-----------------------------------------+--------------------------------+
[!CRITICAL] Rule of Independence : The two authentication factors must belong to two distinct categories . Using two knowledge factors (e.g., entering a password and answering a security question) or two possession factors violates 21 C.F.R. § 1311.115. Furthermore, the physical token (possession factor) must be separate from the computer or mobile device running the EPCS signing application, unless it is a secure cryptographic token embedded in a federally certified hardware container.
Cryptographic Digital Signature & Tamper Evidence
When the prescriber applies 2FA, the software generates a cryptographic digital signature that binds the prescriber's digital identity to the specific data payload of the prescription (patient name, drug, quantity, sig, issuance date). Any post-signing modification of any character within the electronic record alters the cryptographic hash value, causing the pharmacy system to flag the transmission as corrupted, altered, or invalid.
Alabama Electronic Transmission Standards & Intermediary Controls
Under Alabama law and Board regulations, electronic prescriptions must travel directly from the prescriber's electronic software to the dispensing pharmacy's application via a certified secure electronic routing network (e.g., Surescripts). State law imposes strict protections on electronic transmissions:
1. Direct Computer-to-Computer Transmission
The prescription data must be transmitted directly from the prescriber's computer system into the dispensing pharmacy's computer terminal without intermediary intervention that alters the clinical content of the order.
2. Prohibition of Commercial Interception & Marketing Steering
Alabama law strictly prohibits third-party intermediaries, software vendors, or electronic switches from intercepting, screening, modifying, or appending commercial advertising, coupons, or therapeutic alternative steering to a prescription order during electronic transmission. Prescribers and patients retain absolute freedom of pharmacy choice, and software systems cannot redirect prescriptions without explicit patient direction.
3. Patient Confidentiality & HIPAA Compliance
All electronic transmissions must employ advanced encryption standards (AES) meeting federal Health Insurance Portability and Accountability Act (HIPAA) and Alabama patient privacy requirements. Electronic systems must maintain complete audit logs documenting every transmission, routing hop, and delivery confirmation.
Controlled Substance Transmission Restrictions & Fallback Degradation Bans
A critical area of federal and state enforcement concerns the prohibition against downgrading or converting electronic controlled substance prescriptions :
The Ban on Computer-Generated Facsimiles
Under 21 C.F.R. § 1311.170, if an electronic prescription for a controlled substance is transmitted from an EHR system, it must be transmitted electronically and received electronically by the pharmacy's dispensing software. An electronic prescribing system is strictly prohibited from converting an EPCS transmission into a computer-generated facsimile (e-fax) .
A computer-generated fax does not qualify as an EPCS because it lacks end-to-end cryptographic digital signature verification;
A computer-generated fax does not qualify as a valid paper or facsimile prescription because it lacks the prescriber's manual wet signature;
If an EPCS transmission fails, the software cannot automatically re-route the order to the pharmacy's fax machine. Any controlled substance prescription received via computer-generated fax without a manual wet signature is legally invalid and cannot be dispensed. EHR Software EPCS Transmission
- │
- ├───► Transmitted Electronically ───► Dispensed via Certified Pharmacy Application [LEGAL]
- │
- └───► Converted to Computer Fax ───► Pharmacy Fax Terminal (No Wet Signature) [ILLEGAL!]
- Fallback Protocols for Failed Electronic Transmissions
If an EPCS transmission fails to reach the target pharmacy due to technical disruptions:
The prescriber's EHR application must notify the prescriber that the electronic transmission was unsuccessful.
If the prescriber chooses to print the prescription on paper, the EHR software must print a mandatory notice on the face of the paper prescription indicating that the prescription was originally attempted electronically to [Designated Pharmacy Name] on [Date/Time] and that transmission failed .
Dispensing Pharmacy Duty : When a pharmacy receives a paper prescription bearing a failed electronic transmission notice, the dispensing pharmacist must contact the pharmacy named in the notice to verify that the electronic prescription was never received or dispensed. If received but not dispensed, the first pharmacy must void the electronic order before the second pharmacy may dispense from the paper hardcopy.
Recordkeeping, Archiving & Daily Pharmacist Verification Logs
Prescription records generated electronically must be maintained in compliance with rigorous archiving and verification standards:
1. Two-Year Electronic Archiving Mandate
Under both Ala. Code § 34-23-8 and 21 C.F.R. § 1311.200, all electronic prescription records—including digital signatures, timestamps, audit trails, and dispensing histories—must be retained electronically for at least two (2) years . It is impermissible to print electronic prescriptions, discard the electronic database record, and claim compliance based on paper files. The electronic record is the primary legal document and must remain readily retrievable upon request by ALBOP investigators or DEA agents.
2. Searchability and Audit Trail Capabilities
The electronic archiving system must be capable of sorting, filtering, and indexing dispensing records by: prescriber name, patient name, drug name, and date filled. The system must maintain an immutable, tamper-evident audit log tracking every access, modification, or status change.
3. Daily Controlled Substance Dispensing Verification Log
For all controlled substances (Schedules II–V) dispensed via an electronic or automated pharmacy system, Alabama Administrative Code (r. 680-X-3-.08) and federal regulations (21 C.F.R. § 1306.22) mandate that the pharmacy verify daily dispensing accuracy through one of two authorized methods:
Method A: The Daily Hardcopy Printout : The system generates a daily printout of all controlled substance dispensing activity. Each pharmacist who dispensed controlled substances during that day must carefully review the printout, certify its accuracy, and sign and date the document within 72 hours of the dispensing date. These signed daily printouts must be maintained in a separate chronological file for at least two (2) years.
Method B: The Central Electronic Logbook : In lieu of a physical paper printout, the pharmacy management system may maintain a secure, central electronic logbook. Each dispensing pharmacist must log in and sign an electronically generated verification statement each day confirming that the controlled substance dispensing data for that day has been reviewed and is completely accurate.
Technical Comparison: Non-Controlled vs. EPCS Requirements
Technical Feature Non-Controlled Electronic Prescriptions EPCS (Controlled Substances C-II–V)
Software Certification Standard e-prescribing certification Mandatory Independent Third-Party Audit (Part 1311)
- Prescriber Identity Proofing Routine clinic administrative setup Formal NIST SP 800-63 Level 3 Proofing
- Signing Authentication Single-factor (Password or login) Mandatory Two-Factor Authentication (2FA)
- Conversion to Computer Fax Permitted during electronic routing Strictly Prohibited under 21 C.F.R. § 1311.170
- Failed Transmission Fallback Standard paper prescription Paper must annotate failed EPCS attempt & target
- Daily Pharmacist Log General prescription logs Daily signed printout (72 hr) or electronic logbook
- Electronic Archival Period 2 Years minimum under Alabama law 2 Years minimum electronically under DEA & ALBOP